Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22829629 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study
Condition: Osteogenesis Imperfecta
Intervention: Biological: Bone marrow transplant

Indicates status has not been verified in more than two years